Literature DB >> 25540501

Changes in Glucose, TNF-α and IL-6 Blood Levels in Middle-aged Women Associated with Aerobic Exercise and Meditation Training.

Sun Hur1, Gun-Soo Han2, Byung-Jun Cho3.   

Abstract

[Purpose] The purpose of this study was to investigate the effects of exercise therapy on glucose, TNF-α and IL-6 blood levels in middle-aged women. [Subjects] A total of 46 participants were assigned to four groups: Type D personality+Exercise (n=12), Type D+no-Exercise (n=12), not-Type D+Exercise (n=12), and not-Type D+no-Exercise (n=10). [Methods] Blood glucose was measured by the hexokinase method. An enzyme-linked immunosorbent assay (ELISA) was used to measure the circulating plasma levels of TNF-α and IL-6 (Quantikine HS, R&D Systems, Minneapolis, USA). An aerobic exercise program and meditation were conducted in parallel by the Exercise groups for 10 months. Stretching was performed for 10 min as a warm-up, and then walking and running on a treadmill at 60 to 70% of HRmax were performed for 40 min three times a week. Blood samples were processed according to standard laboratory procedures.
[Results] Fasting glucose showed a significant interaction effect among groups, group×time, and post-test. TNF-α showed a significant difference among groups, and was lower in the not-Type D personality+Exercise group than in the other three groups. IL-6 showed a significant difference among the groups.
[Conclusion] In conclusion, personality may affect the established effect of exercise on cytokine activity. Type D personality was independently associated with significant immune activation, and increase in TNF-α activity was observed among Type D participants.

Entities:  

Keywords:  Glucose; IL-6 blood levels; TNF-α

Year:  2014        PMID: 25540501      PMCID: PMC4273061          DOI: 10.1589/jpts.26.1933

Source DB:  PubMed          Journal:  J Phys Ther Sci        ISSN: 0915-5287


INTRODUCTION

Negative emotions are associated with increased production of pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6)1, 2). Episodic psychological risk factors such as depression have been associated with poor prognosis in cardiovascular disease (CVD)3, 4). Chronic psychological risk factors may also affect the clinical manifestations of heart disease5), but individual differences in personality traits have received little attention to date in behavioral immunology research6, 7). Type D personality has been associated with increased levels of inflammatory biomarkers8,9,10,11) and unfavorable cytokine profiles11) in CVD. Preliminary findings for a group of 42 male patients with chronic heart failure (CHF) suggested that Type D personality was associated with the activated immune system characteristic of heart failure syndrome9). The study revealed that, circulating levels of the pro-inflammatory cytokine TNF-α were significantly higher in Type D patients than in not-Type D patients9). Type D personality was also independently associated with increased circulating levels of TNF-α in a subsequent study of CHF patients8). We hypothesized that Type D personality is independently related to immune activation in patients with CHF and severely depressed left ventricular function8). Few studies have investigated whether Type D personality is a physiological factor deciding cytokine concentration increases in CVD. Pro-inflammatory cytokines indicate potential onset of disease in CVD symptom-free people and physical activity or exercise can lower the potential risk levels of CVD12). Regular aerobic exercise reduces CVD risk factors and levels of oxidative stress, and has a positive influence on lipoprotein metabolism13). Also it is reported that meditation increases the nitrogen oxide, a strong vasodilator, level in the body and improves cardiovascular functioning and arteriosclerosis14). Therefore, the aim of this study was to search for an association of Type D personality with pro-inflammatory cytokine levels, through comparison of the pro-inflammatory cytokine levels of middle-aged women who performed an exercise intervention.

SUBJECTS AND METHODS

A total of 46 middle aged women participated in this study. The characteristics of the participants are shown in Table 1. All subjects participated voluntarily and gave their written informed consent. The participants were allocated to one of the following four groups: Type D personality+Exercise (n=12), Type D+no-Exercise (n=12), not-Type D+Exercise (n=12), and not-Type D+no-Exercise (n=10). All participants completed the 14-item Type D Scale (DS14) to assess whether or not they had a Type D personality. The DS14 consists of two subscales, negative affectivity (NA) and social inhibition (SI), both of which comprise 7 items. A standardized cutoff score ≥ 10 on both subscales is used to classify a person as having a Type D personality. In this study, a Korean version of the DS14 developed by Lim et al. was used15). Cronbach’s alpha is 0.82 for the NA subscale and 0.80 for the SI subscale. Subjects who reported going through menopause, drinking, smoking, and performing regular exercise in the past 6 months were excluded from this study. The sample size of this study was estimated prior to data collection by using a power analysis method as previously suggested16). Assuming a medium effect size of 0.25 and an alpha level of 0.05, G*Power 3.1 estimated that at least 8 participants would be necessary. All experiments were reviewed and approved by the Committee of the Kangwon National University. Blood samples were collected following a 12-hour overnight fast. Samples were processed according to standard laboratory procedures. They were processed under the same conditions before exercise and 10 months after exercise. Blood glucose was measured by the hexokinase method17). An enzyme-linked immunosorbent assay (ELISA) was used to measure circulating plasma levels of TNF-α and IL-6 (Quantikine HS, R&D Systems, Minneapolis, USA). An aerobic exercise program and meditation were performed by the Exercise groups three times a week for 10 months. The aerobic exercise program consisted of three parts: a warm-up, walking and running, and cool-down. Before starting walking and running on a treadmill, all the subjects performed stretching for 10 min. This was followed by walking and running on a treadmill at 60 to 70% of HRmax13, 18) for 40 min. In order to accurately check whether the exercise was conducted within the set range of exercise intensity, we monitored the heart rated of the subjects with a wearable automatic portable heart rate meter (Polar Electro, Kempele, Finland). The meditation was performed for 20 minutes. The subjects were asked to sit in the pyramid sitting position and to concentrate on breathing only; therefore, the subjects took only deep breaths using their diaphragm rather than short, shallow breaths from their chest until they felt calm. The ratio of inspiration to expiration breathing began at 1:1 and the ratio was increased to 1:2.
Table 1.

Characteristics of the subjects

VariablesGroupsM±S
Age (years)Type DExercise47.83±1.75
No-Exercise47.58±2.50
Not-Type DExercise46.58±2.43
No-Exercise46.73±1.90
Height (cm)Type DExercise156.55±4.93
No-Exercise157.19±4.74
Not-Type DExercise157.28±6.16
No-Exercise157.86±5.31
Weight (kg)Type DExercise69.21±9.99
No-Exercise66.81±8.00
Not-Type DExercise66.43±4.00
No-Exercise66.89±3.73
Data are presented as means±standard deviation (SD). Two-way repeated measures ANOVA was performed to examine differences between Type D personality and not-Type D. When a significant interaction effect was found between main effects, the paired t-test was performed to compare the effects between groups by time. For comparison of groups by time, one-way ANOVA and Duncan’s post hoc test were performed. SPSS for Windows version 20.0 was used for the statistical analysis, and values of p<0.05 were considered statistically significant.

RESULTS

The changes in glucose and pro-inflammatory cytokines after 10 months of exercise are shown in Table 2. The fasting glucose showed a significant interaction effect among the groups (p<0.001), and group×time (p=0.034), and post hoc test results. The values of the Type D groups were significantly higher than those of the not-Type D groups. The TNF-α levels showed significant differences among the groups (p=0.015), and that of the not-Type D+Exercise group was lower than those of the other three groups. The IL-6 levels showed significant differences among the groups (p=0.014), and times (p=0.044), and was significantly lower in the Exercise groups than in the no-Exercise groups.
Table 2.

The changes in glucose and pro-inflammatory cytokines

VariablesGroupsBeforeAfterDifferencep-valueDuncan
Fasting glucose (mg/dl)Type DExercise103.92±11.0689.92±7.49−14.00
No-Exercise104.08±12.54104.08±12.620.00group <0.001c,a<d,b
Not-Type DExercise95.92±8.8584.75±3.52−11.17time 0.060
No-Exercise100.73±11.96101.00±11.520.27group×time 0.034
TNF-α (pg/ml)Type DExercise8.10±2.126.73±1.77−16.91
No-Exercise7.97±1.988.15±2.272.26group 0.015c<d,a,b
Not-Type DExercise7.04±1.705.55±1.50−21.16time 0.092
No-Exercise7.17±1.707.18±1.680.14group×time 0.276
IL-6 (pg/ml)Type DExercise8.89±2.047.17±1.91−19.35***
No-Exercise8.31±2.118.30±2.12−0.12group 0.014c<d,a,b
Not-Type DExercise7.40±1.975.67±2.01−23.38***Time 0.044
No-Exercise7.23±2.027.23±2.000.00group×time 0.253

Mean±SD. ***p<0.001; **p<0.01; *p<0.05 (by paired t-test). a, Type D+Exercise (n=12); b, Type D+no-Exercise (n=12); c, not-Type D+Exercise (n=12); d, not-Type D+no-Exercise (n=10)

Mean±SD. ***p<0.001; **p<0.01; *p<0.05 (by paired t-test). a, Type D+Exercise (n=12); b, Type D+no-Exercise (n=12); c, not-Type D+Exercise (n=12); d, not-Type D+no-Exercise (n=10)

DISCUSSION

TNF-α and IL-6 blood levels of obesity or diabetic patients are significantly higher than those of normal subjects19). Excessive accumulation of body fat due to obesity and overweight increases blood cytokine levels such as those of TNF-α and IL-6. Ultimately, this increase causes insulin degradation of the liver and skeletal muscle, and increases the risk levels of various degenerative disorders including metabolic syndrome and insulin resistance9, 12). TNF-α and IL-6 have been shown to be implicated in the pathogenesis of CVD20). IL-6 stimulates the production of C-reactive protein and fibrinogen6), and has been associated with increased mortality in CVD21). The most studied inflammatory marker in CVD is TNF-α20). Increased circulating levels of TNF-α have been related to recurrent cardiac events following myocardial infarction and increased mortality in CVD21). In addition, blood levels of TNF-α and IL-6 are closely related with metabolic diseases including obesity and type 2 diabetes mellitus. Our results are consistent with the results of previous studies22) showing that TNF-α and IL-6 levels of obese patients are significantly decreased by moderate walking exercise. For example, Kondo et al.23) measured the body fat and serum cytokine levels of women who participated in an exercise program for seven months. The body fat and body mass index (BMI) of both the normal group and the obese group significantly improved and the blood levels of TNF-α and IL-6 were more significantly improved in the obese group than in the normal group. Dod et al. reported24) that the blood level of IL-6 was significantly improved by a lifestyle modification program prescribing diet and exercise, and stress coping tips for 12 weeks. The cytokine levels of Type D personality subjects increase by more than those of the not-Type D personality subjects when under stress25) and Type D subjects’ precursors of inflammatory response9), and TNF-α levels increase5). In this respect, the results of this study indicate that the reduction of TNF-α and IL-6 blood levels observed after exercise may be a secondary outcome dependent on the decrease in body fat and waist circumference due to exercise, and we judge that the reduction of insulin resistance cytokine expression improves insulin sensitivity contributing to decrease in CVD risk factors. In summary, the results of this study not only suggest the potential role of personality, they also indicate that personality may affect the established effect of exercise on cytokine activity. Type D personality was independently associated with significant immune activation, and the increase in TNF-α activity observed among the Type D participants.
  21 in total

1.  Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

Authors:  A Deswal; N J Petersen; A M Feldman; J B Young; B G White; D L Mann
Journal:  Circulation       Date:  2001-04-24       Impact factor: 29.690

2.  Depressive symptoms and risk of functional decline and death in patients with heart failure.

Authors:  V Vaccarino; S V Kasl; J Abramson; H M Krumholz
Journal:  J Am Coll Cardiol       Date:  2001-07       Impact factor: 24.094

3.  Validity of the Type D personality construct in Danish post-MI patients and healthy controls.

Authors:  Susanne S Pedersen; Johan Denollet
Journal:  J Psychosom Res       Date:  2004-09       Impact factor: 3.006

Review 4.  Cytokines in atherosclerosis: pathogenic and regulatory pathways.

Authors:  Alain Tedgui; Ziad Mallat
Journal:  Physiol Rev       Date:  2006-04       Impact factor: 37.312

5.  Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure.

Authors:  R Faris; H Purcell; M Y Henein; A J S Coats
Journal:  Eur J Heart Fail       Date:  2002-08       Impact factor: 15.534

6.  Cytokines and immune activation in systolic heart failure: the role of Type D personality.

Authors:  Johan Denollet; Viviane M Conraads; Dirk L Brutsaert; Luc S De Clerck; Wim J Stevens; Christiaan J Vrints
Journal:  Brain Behav Immun       Date:  2003-08       Impact factor: 7.217

7.  A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.

Authors:  Michael S Kostapanos; Haralampos J Milionis; Theodosios D Filippatos; Eleni S Nakou; Eleni T Bairaktari; Alexandros D Tselepis; Moses S Elisaf
Journal:  Clin Ther       Date:  2007-07       Impact factor: 3.393

8.  Correlation between serum resistin level and adiposity in obese individuals.

Authors:  Koichiro Azuma; Fuminori Katsukawa; Shuji Oguchi; Mitsuru Murata; Hajime Yamazaki; Akira Shimada; Takao Saruta
Journal:  Obes Res       Date:  2003-08

9.  The relationship between age and production of tumour necrosis factor-alpha in healthy volunteers and patients with chronic heart failure.

Authors:  Stephan von Haehling; Sabine Genth-Zotz; Rakesh Sharma; Aidan P Bolger; Wolfram Doehner; Peter J Barnes; Andrew J S Coats; Stefan D Anker
Journal:  Int J Cardiol       Date:  2003-08       Impact factor: 4.164

10.  Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure.

Authors:  Johan Denollet; Angélique A Schiffer; Martijn Kwaijtaal; Herbert Hooijkaas; Eric H Hendriks; Jos W Widdershoven; Nina Kupper
Journal:  Am J Cardiol       Date:  2008-11-21       Impact factor: 2.778

View more
  4 in total

1.  The effects of four weeks aerobic training on saliva cortisol and testosterone in young healthy persons.

Authors:  Ahmad H Alghadir; Sami A Gabr; Farag A Aly
Journal:  J Phys Ther Sci       Date:  2015-07-22

2.  Effects of Mind-Body Training on Cytokines and Their Interactions with Catecholamines.

Authors:  Joon Hwan Jang; Hye Yoon Park; Ui Soon Lee; Kyung-Jun Lee; Do-Hyung Kang
Journal:  Psychiatry Investig       Date:  2017-07-11       Impact factor: 2.505

3.  Mid-arm muscle circumference: A significant factor of all-cause and cancer mortalities in individuals with elevated platelet-to-lymphocyte ratio.

Authors:  Pi-Kai Chang; Wei-Liang Chen; Li-Wei Wu
Journal:  PLoS One       Date:  2018-12-13       Impact factor: 3.240

4.  Mid-arm muscle circumference as a substantial factor against mortality among people with elevated gamma gaps.

Authors:  Yuan-Ping Chao; Yi-Fen Lai; Tung-Wei Kao; Tao-Chun Peng; Yuan-Yung Lin; Mu-Tsun Shih; Wei-Liang Chen; Li-Wei Wu
Journal:  Oncotarget       Date:  2017-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.